452 related articles for article (PubMed ID: 25772768)
41. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
[TBL] [Abstract][Full Text] [Related]
42. Anti-Müllerian hormone, testosterone and free androgen index following the dose-adjusted unilateral diathermy in women with polycystic ovary syndrome.
Sunj M; Canic T; Jeroncic A; Karelovic D; Tandara M; Juric S; Palada I
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():163-9. PubMed ID: 24965999
[TBL] [Abstract][Full Text] [Related]
43. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
44. Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology.
Sahmay S; Aydın Y; Atakul N; Aydogan B; Kaleli S
Gynecol Endocrinol; 2014 Feb; 30(2):130-4. PubMed ID: 24328568
[TBL] [Abstract][Full Text] [Related]
45. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
[TBL] [Abstract][Full Text] [Related]
46. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
[TBL] [Abstract][Full Text] [Related]
47. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
48. The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.
Fábregues F; Castelo-Branco C; Carmona F; Guimerá M; Casamitjana R; Balasch J
Gynecol Endocrinol; 2011 Apr; 27(4):216-24. PubMed ID: 20500102
[TBL] [Abstract][Full Text] [Related]
49. Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist.
Hagen CP; Sørensen K; Anderson RA; Juul A
Fertil Steril; 2012 Nov; 98(5):1326-30. PubMed ID: 22901847
[TBL] [Abstract][Full Text] [Related]
50. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
[TBL] [Abstract][Full Text] [Related]
51. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome.
Crisosto N; Ladrón de Guevara A; Echiburú B; Maliqueo M; Cavada G; Codner E; Paez F; Sir-Petermann T
Fertil Steril; 2019 Feb; 111(2):381-388. PubMed ID: 30527840
[TBL] [Abstract][Full Text] [Related]
52. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
[TBL] [Abstract][Full Text] [Related]
53. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
Kallio S; Puurunen J; Ruokonen A; Vaskivuo T; Piltonen T; Tapanainen JS
Fertil Steril; 2013 Apr; 99(5):1305-10. PubMed ID: 23260855
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients.
Pappas II; Craig WY; Spratt LV; Spratt DI
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1290-e1300. PubMed ID: 33247919
[TBL] [Abstract][Full Text] [Related]
55. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Codner E; Maliqueo M; Echiburú B; Hitschfeld C; Crisosto N; Pérez-Bravo F; Recabarren SE; Cassorla F
J Clin Endocrinol Metab; 2006 Aug; 91(8):3105-9. PubMed ID: 16720659
[TBL] [Abstract][Full Text] [Related]
56. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
[TBL] [Abstract][Full Text] [Related]
57. The precise ovarian volume is significantly associated with serum concentrations of antimüllerian hormone, the luteinizing hormone/follicle-stimulating hormone ratio, and total testosterone.
Wakimoto Y; Pors SE; Cadenas J; Colmorn L; Ernst E; Dueholm M; Fedder J; Mamsen LS; Kristensen SG; Andersen CY
Fertil Steril; 2020 Feb; 113(2):453-459. PubMed ID: 32106996
[TBL] [Abstract][Full Text] [Related]
58. Twenty years of endocrinologic treatment in transsexualism: analyzing the role of chromosomal analysis and hormonal profiling in the diagnostic work-up.
Auer MK; Fuss J; Stalla GK; Athanasoulia AP
Fertil Steril; 2013 Oct; 100(4):1103-10. PubMed ID: 23809495
[TBL] [Abstract][Full Text] [Related]
59. The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women.
Kristensen SL; Ramlau-Hansen CH; Andersen CY; Ernst E; Olsen SF; Bonde JP; Vested A; Toft G
Fertil Steril; 2012 Mar; 97(3):779-85. PubMed ID: 22244782
[TBL] [Abstract][Full Text] [Related]
60. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.
Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ
Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
